Hi there!
We track 70,000+ AI startups and surface hidden job opportunities that never appear on LinkedIn. Tell us what you're looking for, our AI agent does the searching. It's free and you sign up using Google. Go explore!
DELFI Diagnostics
Delfi Diagnostics detects cancer early, when it is most curable, using high-precision non-invasive blood tests. It uses artificial intelligence and genome sequencing to detect unique patterns of DNA…
DELFI Diagnostics
Delfi Diagnostics detects cancer early, when it is most curable, using high-precision non-invasive blood tests. It uses artificial intelligence and genome sequencing to detect unique patterns of DNA…
TL;DR
Founded: 2019
Headquarters: Baltimore, Maryland
Core tech: Whole-genome cfDNA fragmentomics + machine learning
Flagship product: FirstLook Lung (blood-based lung cancer screening)
Notable financing: $225M Series B (Jul 18, 2022)
Company Overview
Problem Domain
Early cancer detection and monitoring via liquid biopsy
Founded
2019
Industry
Biotechnology Research
Tech Stack
Funding Track Record
5.5M USD
Seed financing reported August 2019
225M USD
Series B announced July 18, 2022
Investor Signal
“Backed by institutional and strategic investors including DFJ Growth, Eli Lilly, Point72, Menlo Ventures, Foresite Capital, OrbiMed, Illumina Ventures, Merck Global Health Innovation Fund and others”
Founders
What we do
Join the Team
Startup jobs. A lot of them.
Your next opportunity is in here somewhere. Sign up to explore 70,000+ startups and their open roles. No spam. No gamification. Just jobs.
70,000+
Startups
83,000+
Open Roles
4,500+
New This Week
Related Companies
| Company |
|---|
 |
 |
 |
 |
 |